PCOS has a new name. What is PMOS, and why does it matter?

Polycystic ovary syndrome (PCOS) has a new name: polyendocrine metabolic ovarian syndrome, or PMOS. The change came from a multi-year international consensus process published in The Lancet in May 2026, involving 56 academic, clinical, and patient organizations and more than 14,000 survey respondents. The goal was to more accurately reflect the condition's full range of hormonal and metabolic features, since "polycystic ovary syndrome" implied ovarian cysts that many people with the condition don't actually have.

Why did researchers decide PCOS needed a new name?

The consensus paper, published by an international research team, explained that the old term was "inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma." The researchers described the process as an unprecedented, rigorous, multistep global consensus effort.

Melanie Cree, MD, PhD, a pediatric endocrinologist at the University of Colorado Anschutz Medical Campus and one of the researchers involved in the process, framed the significance this way: "it's about finally recognizing the full reality of what patients experience."

Does the name change affect diagnosis or treatment right away?

Not immediately. Lubna Pal, MBBS, MS, a reproductive endocrinologist at Yale Medicine who contributed to the surveys behind the name change, cautioned that "this is the beginning of steps in the right direction." Adoption of PMOS across clinical guidelines, medical education, and diagnostic coding systems will take time, and people currently diagnosed with PCOS should not expect changes to their care plan simply because of the new terminology.

What does the condition actually involve?

According to the National Institute of Child Health and Human Development, the condition is a set of symptoms related to a hormonal imbalance that can affect metabolic, cardiovascular, reproductive, and other aspects of health, not only the ovaries. That broader picture is exactly what the new name is intended to reflect.

If you have questions about symptoms, diagnosis, or treatment, the right next step is a conversation with your healthcare provider. Always consult your healthcare provider before starting any new supplement, especially if you are managing a hormonal or reproductive health condition, trying to conceive, or pregnant or breastfeeding.

Supporting hormone health through nutrition, generally speaking

Separate from any specific diagnosis, many women look at whole-food nutrition as one part of supporting general hormone health.† Pink Stork Beef Organ Complex, a whole-food blend of grass-fed liver, heart, kidney, and female-focused organ powders, supplies naturally occurring iron, B-vitamins, and CoQ10 as part of a broader nutritional foundation.† This is general nutritional support and is not intended to diagnose, treat, or manage any specific hormonal condition.

"Every woman deserves to be heard and understood, especially about her own body. Whatever term the medical world uses, what matters most is that women feel equipped with real information and real support."

— Amy Suzanne Upchurch, Founder and CEO of Pink Stork

Frequently asked questions

What does PMOS stand for?

PMOS stands for polyendocrine metabolic ovarian syndrome, the new name for what was previously called polycystic ovary syndrome (PCOS).

When did this name change happen?

The consensus was published in The Lancet in May 2026, following an international process involving dozens of academic and patient organizations.

Do I need to ask my doctor about "PMOS" instead of "PCOS" now?

You can use either term for now. Adoption of the new name across clinical practice and medical records will take time, and your existing diagnosis and care plan remain the same.

Why did the old name cause confusion?

"Polycystic ovary syndrome" implied that ovarian cysts were a core feature, but many people with the condition don't have them, while the condition's metabolic and endocrine features were often overlooked.

Does this name change mean new treatments are available?

No. The name change itself doesn't introduce new treatments. It's intended to improve how the condition is understood, discussed, and researched going forward.

Where can I learn more about the condition itself?

The National Institute of Child Health and Human Development (NICHD) maintains detailed, regularly updated information on symptoms, diagnosis, and treatment approaches.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, especially during pregnancy, breastfeeding, or while managing a medical condition. Keep out of reach of children.